Covalon Technologies Ltd. (TSXV:COV)
Canada · Delayed Price · Currency is CAD 2.210
+0.040 (1.84%)
Jun 1, 2026, 2:06 PM EST
Covalon Technologies Market Cap
Covalon Technologies has a market cap or net worth of CAD 59.93 million as of June 1, 2026. Its market cap has decreased by -14.28% in one year.
Market Cap
59.93M
Enterprise Value
45.14M
Revenue
32.68M
Ranking
n/a
PE Ratio
43.55
Stock Price
2.21
Market Cap Chart
Since September 3, 2004, Covalon Technologies's market cap has increased from 3.06M to 59.93M, an increase of 1,856.81%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 59.93M | 25.62% |
| Dec 31, 2025 | 47.71M | -46.42% |
| Dec 31, 2024 | 89.04M | 240.51% |
| Dec 29, 2023 | 26.15M | -55.61% |
| Dec 30, 2022 | 58.91M | -14.07% |
| Dec 31, 2021 | 68.55M | 130.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.84B |
| Extendicare | 3.08B |
| Trulieve Cannabis | 2.46B |
| Green Thumb Industries | 2.41B |
| Vext Science | 64.40M |
| Sharp Therapeutics | 63.16M |
| Theralase Technologies | 62.06M |
| Quantum BioPharma | 60.79M |